期刊文献+

曲古菌素A对甲状腺癌细胞增殖及凋亡的影响 被引量:2

Effects of Trichostatin A on Inhibiting Growth and Inducing Apoptosis of Thyroid Cancer Cells in Vitro
下载PDF
导出
摘要 目的探讨组蛋白去乙酰化酶抑制剂曲古菌素A体外抑制甲状腺癌细胞增殖、诱导凋亡的作用。方法采用磺酰罗丹明B染色分析法、Hoechst33342/PI双染荧光显微镜检测及PI单染流式细胞仪分析等技术检测曲古菌素A对不同甲状腺癌细胞增殖、凋亡及细胞周期的影响。结果不同浓度的曲古菌素A处理48h,能明显抑制甲状腺癌细胞的增殖,并且随着药物浓度的增加抑制率也增大,各组间及与对照组相比差异均具有统计学意义(F=35.67,P<0.01);双染后镜下观察显示曲古菌素A使甲状腺癌细胞呈明显的凋亡状态,流式细胞仪分析则表明诱导后滤泡状甲状腺癌细胞凋亡峰(Sub-G1)比值升高,与对照组比较其差异有统计学意义(t=6.225,P<0.01)。结论曲古菌素A能显著抑制甲状腺癌细胞体外的增殖及诱导甲状腺癌细胞的凋亡,其作用呈浓度和时间依赖性。 Objective To investigate the effects of Trichostatin A on inhibiting growth and induing apoptosis of thyroid cancer cell lines in vitro.Methods The cytotoxic effects of Trichostatin A on thyroid cancer cells were determined by using SRB assay.DNA content was measured by PI staining through flow cytometry.Apoptosis of thyroid cancer cells induced by Trichostatin A was identified by fluorescence microscopy with Hoechst33342/PI staining.Results After incubation of thyroid cancer cells with Trichostatin A for 48h, the inhibiting rate, with the augment of drug concentration, increased significantly(F = 35.67, P〈0. 01 ). Trichostatin A induced apoptosis of thyroid cancer cells with Sub-G1 phase peak increasing in flow cytometry(t = 6. 225, P〈0. 01 ). Conclusion Trichostatin A possesses inhibiting proliferation and apoptosis inducing activity on thyroid cancer cells. These effects appear to be dose-dependent.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2009年第12期999-1002,共4页 Cancer Research on Prevention and Treatment
基金 江苏省卫生厅重点科研基金资助项目(H200623)
关键词 曲古菌素A 甲状腺癌细胞 细胞增殖 细胞凋亡 Trichostatin A Thyroid cancer cells Cell growth Cell apoptosis
  • 相关文献

参考文献9

  • 1Khochbin S, Verdel A, Lemercier C, et al. Functional significance of histone deacytalase diversity[J]. Curr Opin Genet Dev, 2001,11 (2) :162-166.
  • 2Marks P, Rifkind RA, Richon VM, et al. Histone deacetylases and cancer: causes and therapies [J]. Nat Rev Cancer, 2001,1 (3) : 194-202.
  • 3张一帆.甲状腺癌诱导再分化治疗的研究动向[J].内科理论与实践,2007,2(6):441-443. 被引量:2
  • 4MasakI K, Rob R, Zhan ZR, et al. Low Concentrations of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228), Increase Expression of the Na +/I- Symporter and Iodine Accumulation in Poorly Differentiated Thyroid Carcinoma Cells[J]. JCE & M,2001,86(7) :3430-3435.
  • 5Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anti cancer drug screening [J]. J Natl Cancer Inst, 1990,82 (13) : 1107-11 12.
  • 6Vrana JA, Decker RH, Johnson CR, et al. Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid(SA HA) proceeds through pathways that are regulated by Bcl-2 /Bcl-XL, c-Jun, and p21CIP1, but independent of p53 [J]. Oncogene, 1999,18(50) :7016-7025.
  • 7Bolden JE, PeartMJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors[J]. Nat Rev Drug Discov,2006, 5(9):769-784.
  • 8Park WH, Jung CW, Park JO, et al. Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27,or apoptosis [J]. Int J Oncol,2003,22 (5) : 1129-1134.
  • 9Taghiyev AF, Guseva NV, Sturm MT, et al. Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment[J]. Cancer Biol Ther,2005,4 (4):382-390.

二级参考文献1

  • 1D. Simon,C. K?rber,M. Krausch,J. Segering,P. Groth,R. G?rges,F. Grünwald,H. Müller-G?rtner,C. Schmutzler,J. K?hrle,H. R?her,C. Reiners. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study[J] 2002,European Journal of Nuclear Medicine(6):775~782

共引文献1

同被引文献64

  • 1张波,刘科,陈道达.曲古菌素A对结肠癌Lovo细胞增殖抑制的研究[J].中国普通外科杂志,2007,16(6):574-576. 被引量:4
  • 2Dokmanovic M,Clarke C,Marks PA.Histone deacetylase in hibitors:overview and perpectives[J].Mol Cancer Res,2007,5(10):981-989.
  • 3Vigushin DM,Coombes RC.Histone deacetylase inhibitors in cancer treatment[J].Anticancer Drugs,2002,13(1):1-13.
  • 4Witt O,Deubzer HE,Milde T,et al.HDAC family:what are the cancer relevant targets[J]? Cancer Letters,2009,277:8-21.
  • 5RosatoRR,Maqqio SC,Almenara JA,et al.The histone deacety-lase inhibitor LAQ824 induces human leukemia cell death thmugha process involving XIAP down-regulation,oxidative injury,and the acid sphingomy-elinase-dependent generation of ceramide[J].Mol Pharmacol,2006,69(1):216-225.
  • 6Kim S,Kang JK,Kim YK,et al.Histone deacetylase inhibitor api-cidin induces cyclin E expression through Sp1 sites[J].Biochem Biophys Res Commun,2006,342(4):1168-1173.
  • 7Archer SY,Meng S,Shei A,et al.p21(WAF1) is required for buty-rate-mediated growth inhibition of human colon cancer cells[J].Proc Natl Acad Sci USA,1998,95(12):6791-6796.
  • 8Ouwehand K,deRuijter AJ,van Bree C,et al.Histone deacetylase in-hibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins[J].FEBS Lett,2005,579(6):1523-1528.
  • 9Fang JY.Histone deacetylase inhibitors,anticancerous mechanism and therapy for gastrointestinal cancers[J].J Gastroenterol Hepato,2005,20(7):988-994.
  • 10Sakajiri S,Kumagai T,Kawamata N,et al.Histone deacetylase inhibi-tors profoundly decrease proliferation of human lymphoid cancer cell lines[J].Exp Hemato,2005,33(1):53-61.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部